Cri du Chat

01Pathophysiology

Cri du Chat syndrome results from a heterozygous deletion on the short arm of chromosome 5 (designated 5p-). The size of the deletion varies among patients, but the phenotypic hallmarks map to two critical regions. The gene responsible for the characteristic cry has been localized to 5p15.3, while the region at 5p15.2 is linked to the intellectual disability and dysmorphic facial features. Loss of the CTNND2 gene (encoding delta-catenin, a neuronal adhesion protein) within this interval is thought to contribute heavily to the neurodevelopmental phenotype.

The catlike cry, the single most recognizable feature of this syndrome, is caused by structural abnormalities of the larynx and epiglottis. The larynx is small, narrow, and diamond-shaped rather than the normal rounded configuration. The epiglottis is often hypoplastic and floppy. These anatomical changes produce a high-pitched, monotone wail that is strikingly similar to a cat's mewing. Importantly, this cry tends to become less distinctive as the child ages, which is why vignettes almost always present an infant or neonate rather than an older child.

Microcephaly results from impaired neuronal migration and cortical development secondary to haploinsufficiency of genes within the deleted segment. The round facies in infancy gradually elongates with age, so older children may not exhibit the classic "moon face." Intellectual disability is moderate to severe and is present in virtually all affected individuals. Hypotonia in infancy often transitions to hypertonia as the child grows, a detail occasionally tested.

Approximately 15-20% of patients have congenital heart defects, most commonly ventricular septal defect (VSD), atrial septal defect (ASD), or patent ductus arteriosus (PDA). This is clinically relevant because cardiac evaluation is part of the initial workup once the diagnosis is suspected.

Most cases (~85%) are de novo deletions occurring during gametogenesis, meaning the parents have normal karyotypes. However, in roughly 10-15% of cases, one parent carries a balanced translocation involving chromosome 5. In these families, the recurrence risk is significantly elevated, making parental karyotyping an important counseling step once a child is diagnosed.

02Clinical Manifestation and Classification

There is no formal staging or grading system for Cri du Chat syndrome. However, the size of the deletion correlates roughly with clinical severity: larger deletions tend to produce more pronounced intellectual disability and a greater burden of associated anomalies, while smaller, terminal deletions may present with milder cognitive impairment and a more subtle phenotype.

03Diagnostic Workup

The diagnosis begins with clinical suspicion. The combination of a high-pitched, catlike cry in a neonate with microcephaly, round face, and feeding difficulties should immediately raise concern for Cri du Chat syndrome. This is the classic vignette trigger.

The best initial test in practice is a standard G-banded karyotype, which can identify the 5p deletion when it is large enough to be visible under light microscopy. Most deletions in Cri du Chat are detectable this way, as they tend to involve several megabases of DNA.

When the karyotype appears normal but clinical suspicion remains high, or when you need to precisely define the deletion boundaries, chromosomal microarray (CMA) is the most accurate test. CMA has become the recommended first-tier cytogenetic test for children with unexplained developmental delay or intellectual disability according to current guidelines, and it will detect deletions too small for conventional karyotyping. FISH using a probe targeted to 5p15 is another confirmatory option, particularly useful when you already suspect this diagnosis and want rapid targeted confirmation.

Once the child is diagnosed, parental karyotyping is essential. If a parent carries a balanced translocation, the recurrence risk in future pregnancies rises substantially (potentially up to 15-25% depending on the translocation), and the family should be referred for genetic counseling. If both parents have normal karyotypes, the deletion is de novo and the recurrence risk is low (around 1% or less, accounting for the small possibility of germline mosaicism).

Echocardiography and renal ultrasound should be obtained as part of the initial evaluation to screen for congenital heart defects and structural kidney anomalies, both of which occur at increased frequency.

04Management and Treatment

There is no curative treatment for Cri du Chat syndrome. Management is entirely supportive, multidisciplinary, and tailored to the individual child's needs. The goals are to maximize developmental potential and quality of life.

In the neonatal period, the immediate priorities are feeding support and screening for associated anomalies. Many infants have significant oral motor dysfunction and gastroesophageal reflux, requiring occupational therapy intervention and sometimes temporary nasogastric feeding. Proton pump inhibitors or H2 blockers may be used for reflux management at standard pediatric dosing (e.g., omeprazole 1 mg/kg/day in infants, adjusted as needed).

Cardiac defects, if present and hemodynamically significant, are managed surgically according to standard pediatric cardiology protocols. Small, asymptomatic VSDs may be monitored conservatively, while larger defects or those causing heart failure symptoms require earlier intervention.

Early intervention is the cornerstone of long-term management. Enrollment in a comprehensive early intervention program as soon as the diagnosis is established significantly improves outcomes. Speech therapy is particularly important because most patients with Cri du Chat develop very limited expressive language, and alternative communication strategies (picture boards, sign language, electronic devices) become critical tools. Physical therapy addresses the progression from infantile hypotonia to later hypertonia and helps promote acquisition of motor milestones, which are universally delayed.

Behavioral issues including self-stimulatory behavior, aggression, and hyperactivity often emerge in the school-age years. Structured behavioral programs and, in select cases, pharmacologic management of hyperactivity or aggression may be considered, though there is no Cri du Chat-tailored pharmacologic protocol.

Life expectancy is not dramatically shortened in the absence of severe cardiac malformations. Most individuals survive into adulthood, though they require lifelong supervision and support.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get questions about Cri du Chat wrong is by confusing it with other chromosomal abnormalities that share overlapping features. A vignette describing a hypotonic infant with epicanthal folds, a single palmar crease, and a congenital heart defect can easily be mistaken for Down syndrome if the student does not pay attention to the cry description and the head circumference. Down syndrome does not produce a catlike cry, and the head size in Down syndrome is typically normal or only mildly reduced, whereas Cri du Chat features true microcephaly. The cry is the single most discriminating feature and is almost always embedded in the stem.

A second trap involves confusing Cri du Chat with Wolf-Hirschhorn syndrome, since both are autosomal deletion syndromes affecting nearby chromosomes (5p vs. 4p) with overlapping features of growth restriction, intellectual disability, and dysmorphic facies. The discriminator is the facial appearance ("Greek warrior helmet" facies and prominent seizure history in Wolf-Hirschhorn vs. round face and catlike cry in Cri du Chat).

A third pearl: students sometimes forget to recommend parental karyotyping when asked about the next step after confirming the diagnosis. If the question stem establishes the diagnosis and asks what to do next for the family, the answer is parental chromosome analysis to assess for a balanced translocation and counsel about recurrence risk.

Finally, remember that the catlike cry diminishes with age. If a vignette presents an older child with intellectual disability, microcephaly, and a history of an unusual cry in infancy (but the cry is no longer present), you should still think of Cri du Chat. The test-writer is checking whether you can recognize the syndrome beyond its most classic neonatal presentation.

The core competency being tested is your ability to recognize a pattern of findings (distinctive cry + microcephaly + dysmorphic facies) and map it to the correct chromosomal abnormality, then demonstrate knowledge of the appropriate genetic workup and family counseling steps.